4//SEC Filing
KOZARICH JOHN W 4
Accession 0002001011-25-000096
CIK 0000886163other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 5:22 PM ET
Size
11.0 KB
Accession
0002001011-25-000096
Insider Transaction Report
Form 4
KOZARICH JOHN W
Director
Transactions
- Sale
Common Stock
2025-11-03$191.25/sh−207$39,589→ 44,715 total - Sale
Common Stock
2025-11-03$189.00/sh−84$15,876→ 44,971 total - Sale
Common Stock
2025-11-03$190.26/sh−49$9,323→ 44,922 total - Sale
Common Stock
2025-11-03$192.38/sh−127$24,432→ 44,588 total
Footnotes (5)
- [F1]The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $188.7150 to $189.5250. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $189.7800 to $190.5750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $190.9400 to $191.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $192.1200 to $192.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001223000
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 5:22 PM ET
- Size
- 11.0 KB